BridgeBio Oncology Therapeutics ($BBOT) Insider Trading & Smart Money Activity

BridgeBio Oncology Therapeutics, Inc. · Biotechnology · Latest filing Jun 22, 2026

BridgeBio Oncology Therapeutics, Inc. ($BBOT) has 2 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

2

BBOT insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All BBOT insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 22, 2026	Analyst	Oppenheimer	Raises to buy		PT $22		-2.7%	+13.1%			Read
Jun 22, 2026	Analyst	Oppenheimer	Raises to buy		PT $22		-2.7%	+13.1%			Read

1W / 1M / 6M = how BBOT moved from the trade or filing date.

Analyst ratings on BBOT

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 22, 2026	Oppenheimer	Raises	buy	$22	-2.7%	+13.1%		Read
Jun 22, 2026	Oppenheimer	Raises	buy	$22	-2.7%	+13.1%		Read

Other biotechnology stocks

• $OBIO
• $AGEN
• $RZLT
• $BNTC
• $PROK
• $ARTV
• $TRXB
• $LRMR

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.